{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:03:06Z","timestamp":1788814986245,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005261","name":"Centre Hospitalier R\u00e9gional Universitaire de Montpellier","doi-asserted-by":"publisher","award":["34000"],"award-info":[{"award-number":["34000"]}],"id":[{"id":"10.13039\/501100005261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.waojou.2023.100809","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T06:47:43Z","timestamp":1692427663000},"page":"100809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers"],"prefix":"10.1016","volume":"16","author":[{"given":"Marie","family":"Douillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zineb","family":"Deheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Bozon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Raison-Peyron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dereure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Moulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e8le","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-1977","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Du-Thanh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.waojou.2023.100809_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2222.2009.03323.x","article-title":"Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors","volume":"40","author":"Hoover","year":"2010","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2023.100809_bib2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jaip.2017.02.018","article-title":"Epidemiology and incidence of ACE inhibitor angioedema utilizing a large electronic health record","volume":"5","author":"Banerji","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.waojou.2023.100809_bib3","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1, Supplement","key":"10.1016\/j.waojou.2023.100809_bib4","doi-asserted-by":"crossref","first-page":"169S","DOI":"10.1378\/chest.129.1_suppl.169S","article-title":"Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines","volume":"129","author":"Dicpinigaitis","year":"2006","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.waojou.2023.100809_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF03261835","article-title":"Tolerability of angiotensin-receptor blockers in patients with intolerance to angiotensin-converting enzyme inhibitors","volume":"12","author":"Caldeira","year":"2012","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.waojou.2023.100809_bib6","unstructured":"Therapeutic Efficacy of Icatibant in Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: A Case Series - ScienceDirect [Internet]. [cited 2022 Mar 6]. Available from: %https:\/\/www-sciencedirect-com.ezpum.scdi-montpellier.fr\/science\/article\/pii\/S0196064410002799?via%3Dihub."},{"key":"10.1016\/j.waojou.2023.100809_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13023-018-0815-5","article-title":"Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies","volume":"13","author":"Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.waojou.2023.100809_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/20009666.2019.1698259","article-title":"Clinical features of angioedema induced by renin-angiotensin-aldosterone system inhibition: a retrospective analysis of 84 patients","volume":"9","author":"Pfaue","year":"2019","journal-title":"J\u00a0Community Hosp Intern Med Perspect"},{"issue":"5","key":"10.1016\/j.waojou.2023.100809_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1081-1206(10)60288-8","article-title":"Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis","volume":"101","author":"Haymore","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.waojou.2023.100809_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MEJ.0000000000000446","article-title":"Diagnosis and treatment of upper airway oedema caused by acute angio-oedema in the emergency department: a French consensus statement","volume":"24","author":"Floccard","year":"2017","journal-title":"Eur J Emerg Med"},{"issue":"8","key":"10.1016\/j.waojou.2023.100809_bib11","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/archinte.164.8.910","article-title":"Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment","volume":"164","author":"Cicardi","year":"2004","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.waojou.2023.100809_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.amjhyper.2003.09.014","article-title":"Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial","volume":"17","author":"Kostis","year":"2004","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.waojou.2023.100809_bib13","unstructured":"Angioedema Incidence in US Veterans Initiating Angiotensin-Converting Enzyme Inhibitors [Internet]. [cited 2022 Apr 1]. Available from: https:\/\/www.ahajournals.org\/doi\/epub\/10.1161\/HYPERTENSIONAHA.108.110270."},{"issue":"1","key":"10.1016\/j.waojou.2023.100809_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/20009666.2020.1711641","article-title":"ACE inhibitor angioedema: characterization and treatment versus non-ACE angioedema in acute hospitalized patients","volume":"10","author":"Weisman","year":"2020","journal-title":"J\u00a0Community Hosp Intern Med Perspect"},{"issue":"4","key":"10.1016\/j.waojou.2023.100809_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.revmed.2012.12.017","article-title":"Prise en charge des angi\u0153d\u00e8mes induits par les inhibiteurs de l\u2019enzyme de conversion de l\u2019angiotensine : recommandations du Centre de r\u00e9f\u00e9rence national des angi\u0153d\u00e8mes","volume":"34","author":"Nosbaum","year":"2013","journal-title":"Rev M\u00e9decine Interne."},{"issue":"3, Supplement","key":"10.1016\/j.waojou.2023.100809_bib16","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","article-title":"Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond","volume":"114","author":"Agostoni","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.waojou.2023.100809_bib17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/all.12313","article-title":"The EAACI\/GA2LEN\/EDF\/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update","volume":"69","author":"Zuberbier","year":"2014","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.waojou.2023.100809_bib18","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2023.100809_bib19","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/HYPERTENSIONAHA.109.134197","article-title":"Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema","volume":"54","author":"Brown","year":"2009","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.waojou.2023.100809_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12948-021-00164-7","article-title":"Angioedema associated with dipeptidyl peptidase-IV inhibitors","volume":"19","author":"Cassano","year":"2021","journal-title":"Clin Mol Allergy CMA"},{"issue":"1","key":"10.1016\/j.waojou.2023.100809_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/HYPERTENSIONAHA.107.096552","article-title":"Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor\u2013associated angioedema","volume":"51","author":"Byrd","year":"2008","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.waojou.2023.100809_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.7326\/L16-0649","article-title":"Sitagliptin and angioedema","volume":"167","author":"Arcani","year":"2017","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.waojou.2023.100809_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1570161112666140226121627","article-title":"Kinin receptors in vascular biology and pathology","volume":"12","author":"Couture","year":"2014","journal-title":"Curr Vasc Pharmacol"},{"issue":"45","key":"10.1016\/j.waojou.2023.100809_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001939","article-title":"Angioedema related to angiotensin-converting enzyme inhibitors","volume":"94","author":"Javaud","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.waojou.2023.100809_bib25","unstructured":"Interactive Effect of Ethnicity and ACE Insertion\/Deletion Polymorphism on Vascular Reactivity [Internet]. [cited 2022 Mar 30]. Available from: https:\/\/www.ahajournals.org\/doi\/epub\/10.1161\/01.HYP.37.1.46."},{"key":"10.1016\/j.waojou.2023.100809_bib26","unstructured":"Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches - PubMed [Internet]. [cited 2022 Apr 8]. Available from: https:\/\/pubmed-ncbi-nlm-nih-gov.ezpum.biu-montpellier.fr\/31710633\/."},{"key":"10.1016\/j.waojou.2023.100809_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.914376","article-title":"Molecular genetic screening in patients with ACE inhibitor\/angiotensin receptor blocker-induced angioedema to explore the role of hereditary angioedema genes","volume":"13","author":"Mathey","year":"2022","journal-title":"Front Genet"},{"issue":"9","key":"10.1016\/j.waojou.2023.100809_bib28","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1503\/cmaj.060535","article-title":"Angioedema without urticaria: a large clinical survey","volume":"175","author":"Zingale","year":"2006","journal-title":"CMAJ Can Med Assoc J"},{"issue":"5","key":"10.1016\/j.waojou.2023.100809_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJMoa1312524","article-title":"A\u00a0randomized trial of icatibant in ACE-inhibitor\u2013induced angioedema","volume":"372","author":"Ba\u015f","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.waojou.2023.100809_bib30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.waojou.2023.100809_bib31","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jaip.2017.03.003","article-title":"Randomized trial of icatibant for angiotensin-converting enzyme inhibitor\u2013induced upper airway angioedema","volume":"5","author":"Sinert","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2023.100809_bib32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaci.2016.09.051","article-title":"Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema","volume":"140","author":"Straka","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.waojou.2023.100809_bib33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/imj.12799","article-title":"Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: icatibant in ACE-I associated angioedema","volume":"45","author":"Fok","year":"2015","journal-title":"Intern Med J"},{"issue":"3","key":"10.1016\/j.waojou.2023.100809_bib34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jama.1997.03550030072037","article-title":"Recurrent angiotensin-converting enzyme inhibitor\u2014associated angioedema","volume":"278","author":"Brown","year":"1997","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.waojou.2023.100809_bib35","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.waojou.2023.100809_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.amjcard.2012.03.034","article-title":"Meta-analysis of randomized trials of angioedema as an adverse event of renin\u2013angiotensin system inhibitors","volume":"110","author":"Makani","year":"2012","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.waojou.2023.100809_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/joim.12867","article-title":"Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study","volume":"285","author":"Rasmussen","year":"2019","journal-title":"J\u00a0Intern Med"},{"issue":"5","key":"10.1016\/j.waojou.2023.100809_bib38","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2022.02.010","article-title":"ACC\/AHA joint committee members. 2022 AHA\/ACC\/HFSA guideline for the management\u00a0of heart failure","volume":"28","year":"2022","journal-title":"J\u00a0Card Fail"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455123000698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455123000698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:46:37Z","timestamp":1761849997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455123000698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1939455123000698"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2023.100809","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2023.100809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100809"}}